Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feedergsk.com
Press releases
Get the latest updates from Press releases directly as they happen.
Follow now 477 followers
Latest posts
Last updated 1 day ago
GSK announces FIRST trial met its primary endpoint of progression free survival in first line advanced ovarian cancer
1 day ago
GSK announces headline results from the FIRST-ENGOT-OV44 phase III trial.
ViiV Healthcare announces CHMP positive opinion for Vocabria + Rekambys, the first and only complete long-acting HIV treatment, for adolescents in Europe
5 days ago
Vocabria + Rekambys is the first and only complete long-acting regimen for...
GSK’s B7-H3-targeted antibody-drug conjugate, GSK’227, receives EMA Priority Medicines (PRIME) Designation in relapsed extensive-stage small-cell lung cancer
5 days ago
Regulatory designation based on promising preliminary clinical data.
Jemperli (dostarlimab) receives US FDA Breakthrough Therapy Designation for locally advanced dMMR/MSI-H rectal cancer
5 days ago
Designation based on data showing no evidence of disease in 100% of...
Jemperli (dostarlimab) plus chemotherapy receives positive CHMP opinion to expand approval to all adult patients with primary advanced or recurrent endometrial cancer
5 days ago
Positive opinion based on statistically significant and clinically meaningful progression-free and overall...
Blenrep shows significant overall survival benefit, reducing the risk of death by 42% in multiple myeloma at or after first relapse
12 days ago
DREAMM-7 trial shows sustained overall survival benefit for Blenrep (belantamab mafodotin) combination...
US FDA accepts GSK’s submission for the use of Nucala (mepolizumab) in COPD
12 days ago
Nucala could be the first approved biologic with monthly dosing for patients...
Blenrep (belantamab mafodotin) combination accepted for priority review in China in relapsed/refractory multiple myeloma
12 days ago
Regulatory submission supported by phase III head-to-head DREAMM-7 trial showing statistically significant...
GSK and Zhifei revise and extend strategic vaccine collaboration in China
16 days ago
Shingrix collaboration extended to 2034
First single-dose medicine for P. vivax malaria prequalified by WHO and included in WHO Guidelines
17 days ago
Important steps to advance access to first single-dose malaria treatment
GSK’s fully liquid Menveo meningococcal vaccine approved by European Commission
24 days ago
Formulation supports simplification of vaccination process against invasive meningococcal disease (IMD).
Blenrep combinations accepted for review by the US FDA for the treatment of relapsed/refractory multiple myeloma
26 days ago
Regulatory submission supported by phase III head-to-head DREAMM-7 and DREAMM-8 trials showing...